[HTML][HTML] Cholecalciferol supplementation lowers leptin and TMAO but increases NO and VEGF-A levels in obese vitamin D deficient patients: Is it one of the potential …
M Ozorowski, M Wiciński, Ł Wróbel… - Nutrition & …, 2022 - Springer
Background Vitamin D deficiency is one of the most common health issues in developed
countries. Obese patients are most at risk of having serum 25-hydroxyvitamin D3 (25 (OH) …
countries. Obese patients are most at risk of having serum 25-hydroxyvitamin D3 (25 (OH) …
Cholecalciferol supplementation lowers leptin and TMAO but increases NO and VEGF-A levels in obese vitamin D deficient patients: Is it one of the potential …
M Ozorowski, M Wiciński, Ł Wróbel… - Nutrition & …, 2022 - search.ebscohost.com
Background: Vitamin D deficiency is one of the most common health issues in developed
countries. Obese patients are most at risk of having serum 25-hydroxyvitamin D< sub> 3(25 …
countries. Obese patients are most at risk of having serum 25-hydroxyvitamin D< sub> 3(25 …
Cholecalciferol supplementation lowers leptin and TMAO but increases NO and VEGF-A levels in obese vitamin D deficient patients: Is it one of the potential …
M Ozorowski, MÅ WiciÅski, Å Wróbel… - Nutrition & …, 2022 - go.gale.com
Background Vitamin D deficiency is one of the most common health issues in developed
countries. Obese patients are most at risk of having serum 25-hydroxyvitamin D. sub. 3 (25 …
countries. Obese patients are most at risk of having serum 25-hydroxyvitamin D. sub. 3 (25 …
Cholecalciferol supplementation lowers leptin and TMAO but increases NO and VEGF-A levels in obese vitamin D deficient patients: Is it one of the potential …
M Ozorowski, M Wiciński, Ł Wróbel… - Nutrition & …, 2022 - pubmed.ncbi.nlm.nih.gov
Background Vitamin D deficiency is one of the most common health issues in developed
countries. Obese patients are most at risk of having serum 25-hydroxyvitamin D 3 (25 (OH) D …
countries. Obese patients are most at risk of having serum 25-hydroxyvitamin D 3 (25 (OH) D …
[HTML][HTML] Cholecalciferol supplementation lowers leptin and TMAO but increases NO and VEGF-A levels in obese vitamin D deficient patients: Is it one of the potential …
M Ozorowski, M Wiciński… - Nutrition & …, 2022 - nutritionandmetabolism …
Vitamin D deficiency is one of the most common health issues in developed countries.
Obese patients are most at risk of having serum 25-hydroxyvitamin D3 (25 (OH) D3) levels …
Obese patients are most at risk of having serum 25-hydroxyvitamin D3 (25 (OH) D3) levels …
[PDF][PDF] Cholecalciferol supplementation lowers leptin and TMAO but increases NO and VEGF-A levels in obese vitamin D deficient patients: Is it one of the potential …
M Ozorowski, M Wiciński, Ł Wróbel… - 2022 - omega.umk.pl
Background: Vitamin D deficiency is one of the most common health issues in developed
countries. Obese patients are most at risk of having serum 25‑hydroxyvitamin D3 (25 (OH) …
countries. Obese patients are most at risk of having serum 25‑hydroxyvitamin D3 (25 (OH) …
[PDF][PDF] Cholecalciferol supplementation lowers leptin and TMAO but increases NO and VEGF-A levels in obese vitamin D deficient patients: Is it one of the potential …
M Ozorowski, M Wiciński, Ł Wróbel… - 2022 - academia.edu
Background: Vitamin D deficiency is one of the most common health issues in developed
countries. Obese patients are most at risk of having serum 25‑hydroxyvitamin D3 (25 (OH) …
countries. Obese patients are most at risk of having serum 25‑hydroxyvitamin D3 (25 (OH) …
Cholecalciferol supplementation lowers leptin and TMAO but increases NO and VEGF-A levels in obese vitamin D deficient patients: Is it one of the potential …
M Ozorowski, M Wiciński, Ł Wróbel… - 2022 - agris.fao.org
Background Vitamin D deficiency is one of the most common health issues in developed
countries. Obese patients are most at risk of having serum 25-hydroxyvitamin D3 (25 (OH) …
countries. Obese patients are most at risk of having serum 25-hydroxyvitamin D3 (25 (OH) …
Cholecalciferol supplementation lowers leptin and TMAO but increases NO and VEGF-A levels in obese vitamin D deficient patients: Is it one of the potential …
M Ozorowski, M Wiciński, Ł Wróbel… - Nutrition & …, 2022 - search.proquest.com
Background Vitamin D deficiency is one of the most common health issues in developed
countries. Obese patients are most at risk of having serum 25-hydroxyvitamin D 3 (25 (OH) D …
countries. Obese patients are most at risk of having serum 25-hydroxyvitamin D 3 (25 (OH) D …
Cholecalciferol supplementation lowers leptin and TMAO but increases NO and VEGF-A levels in obese vitamin D deficient patients: is it one of the potential …
M Ozorowski, M Wiciński, Ł Wróbel… - 2022 - cabidigitallibrary.org
Background: Vitamin D deficiency is one of the most common health issues in developed
countries. Obese patients are most at risk of having serum 25-hydroxyvitamin D3 (25 (OH) …
countries. Obese patients are most at risk of having serum 25-hydroxyvitamin D3 (25 (OH) …